PHOENIX and BEVERLY, Mass., July 15, 2021 /PRNewswire/ -- Amidst the darkness of the pandemic, a shining light from the COVID-19 response is the proliferation of better, faster, more accurate — and ...

The availability, speed and effectiveness of genomic sequencing increased dramatically during the pandemic, as scientists worldwide rushed to find ways to track and predict the virus's movement and ...

SAN DIEGO, Nov. 13, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the Global Health Access Initiative ...

Metagenomic sequencing (mNGS) is a powerful diagnostic tool to detect causative pathogens in clinical microbiological testing. Rapid and accurate classification of metagenomic sequences is a critical ...

Illumina, Inc. ILMN recently launched the Global Health Access Initiative to support the acceleration of pathogen sequencing in low and middle-income countries (LMICs). The program aims to provide ...

A new Global Health Access Initiative, launched by Illumina, is designed to support access to pathogen sequencing tools for public health in low- and middle-income countries (LMICs). The program will ...

Rapid advances in DNA sequencing technology (“next-generation sequencing”) have inspired optimism about the potential of human genomics for “precision medicine.” Meanwhile, pathogen genomics is ...

Pathogen surveillance is the process of constantly monitoring pathogens and analyzing their genetic material. By analyzing the genetic makeup of pathogens, scientists can track their spread, detect ...

Multisectoral partnership will deliver tools and expertise to identify and stop COVID-19 and other disease threats, strengthening leadership for health security in Africa ADDIS ABABA, ETHIOPIA, 12 ...

In a recent study posted to the medRxiv* preprint server, researchers identified a wide variety of pathogenic organisms using plasma microbial cell-free deoxyribonucleic acid (mcfDNA) sequencing.